Liver Transplantation
📧 Sign up to get email alerts when something new happens for Liver Transplantation.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2015-08-04FDA Approved: MYFORTIC — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for MYFORTIC (mycophenolic acid) from Novartis Pharmaceuticals Corporation.
-
FDA approval · 2015-05-28FDA Approved: SIROLIMUS — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for sirolimus submitted by Mylan Pharmaceuticals, granting regulatory approval for changes to th…
-
CLINICAL_TRIALS trial_result · 2015-05-01Clinical Trial Update: A Study to Demonstrate Safety and Efficacy of Advagraf in Patients Undergoing Kidney or Liver Transplantation in India [Phase 4]
A Phase 4 clinical trial evaluating Advagraf (tacrolimus) for safety and efficacy in kidney and liver transplant recipients in India has com…
-
CLINICAL_TRIALS trial_result · 2015-03-18Clinical Trial Update: Evaluation of Thymoglobulin Induction and Reduced Doses of Calcineurin Inhibitors on Liver Transplant Rejection [Phase 2]
Phase 2 trial evaluating thymoglobulin induction with reduced doses of calcineurin inhibitors in liver transplant recipients to prevent reje…
-
CLINICAL_TRIALS research · 2015-01-21Clinical Trial Update: Effects of Preconditioning With Sevoflurane During Organ Procurement From Brain Dead Donors: Impact on Early Function of Liver Allografts [Phase 4]
This Phase 4 clinical trial update from the University of Liege investigates whether preconditioning donor organs with sevoflurane during pr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-08-26Clinical Trial Update: Sequential Therapy (FK506 + Monoclonal Anti-IL2R Antibodies + MMF) Versus FK506 With Steroids in Liver TX [Phase 2]
Phase 2 liver transplantation trial comparing sequential therapy with tacrolimus plus an anti-IL-2 receptor monoclonal antibody and mycophen…
-
CLINICAL_TRIALS trial_result · 2014-07-25Clinical Trial Update: The Effects of Glucose/Ischemic Preconditioning on Reperfusion Injury in Deceased-Donor Liver Transplantation [Phase 3]
Phase 3 clinical trial evaluating glucose/ischemic preconditioning to reduce reperfusion injury in deceased-donor liver transplantation; the…
-
FDA approval · 2014-07-22FDA Approved: TACROLIMUS — Original Application (Strides Pharma Science Limited)
FDA approved Strides Pharma Science Limited's tacrolimus original application, enabling a generic tacrolimus product for prevention of organ…
-
CLINICAL_TRIALS trial_result · 2014-07-14Clinical Trial Update: A Study of CellCept (Mycophenolate Mofetil) in Combination Therapy in Liver Transplant Patients. [Phase 4]
Phase 4 clinical trial evaluating CellCept (mycophenolate mofetil) in combination therapy for liver transplant patients has completed, with …
-
CLINICAL_TRIALS research · 2014-02-17Clinical Trial Update: Prospective Tacrolimus Pharmacokinetics Study in Pediatric Living Donor Liver Transplantation [Phase 4]
This update reports a Phase 4 prospective pharmacokinetics study of tacrolimus in pediatric living-donor liver transplant recipients.
-
CLINICAL_TRIALS trial_result · 2013-12-25Clinical Trial Update: Vecuronium Requirements According to the Operation Phase During Liver Transplantation Under Desflurane Anesthesia
This completed clinical trial evaluated how vecuronium requirements change during different phases of liver transplantation performed under …
-
CLINICAL_TRIALS withdrawal · 2013-12-20Clinical Trial Update: Pilot Study of Immunosuppression Drug Weaning in Liver Recipients Exhibiting Biomarkers of High Likelihood of Tolerance [NA]
A pilot trial evaluating weaning of immunosuppressive therapy in liver transplant recipients with biomarkers suggesting high tolerance was t…
-
CLINICAL_TRIALS withdrawal · 2013-12-09Clinical Trial Update: Enteric Coated Myfortic for Liver Transplant Recipients [Phase 4]
Phase 4 trial evaluating enteric-coated mycophenolate mofetil (Myfortic) for liver transplant recipients has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2013-10-11Clinical Trial Update: Early Rehabilitation Program is Feasible and Safe in ICU in Liver Transplanted Patients [NA]
A clinical trial update reports that an early rehabilitation program in the ICU for liver transplant recipients is feasible and safe.
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: A Study to Assess the Pharmacokinetics of a Modified-release Tacrolimus Based Immunosuppression Regimen in Stable Liver Transplant Patients [Phase 2]
A Phase 2 study evaluating the pharmacokinetics of a modified-release tacrolimus–based immunosuppression regimen in stable liver transplant …
-
FDA approval · 2013-09-27FDA Approved: CELLCEPT — Supplemental Application (Genentech, Inc.)
FDA approved a supplemental application for CELLCEPT (mycophenolate mofetil) submitted by Genentech, Inc.
-
FDA approval · 2013-09-27FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Strides Pharma Science Limited)
FDA approved a supplemental application for a generic mycophenolate mofetil product from Strides Pharma Science Limited, enabling its market…
-
FDA approval · 2013-09-04FDA Approved: PROGRAF — Supplemental Application (Astellas Pharma US, Inc.)
The FDA approved a supplemental application for PROGRAF (tacrolimus) submitted by Astellas Pharma US, Inc. The action relates to an update o…
-
FDA approval · 2013-08-16FDA Approved: PROGRAF — Supplemental Application (Astellas Pharma US, Inc.)
FDA approves a supplemental application for PROGRAF (tacrolimus) filed by Astellas Pharma US, approving changes to the product labeling.
-
FDA approval · 2013-07-19FDA Approved: ASTAGRAF XL — Original Application (Astellas Pharma US, Inc.)
FDA approved ASTAGRAF XL (tacrolimus extended-release capsules) under an Original Application from Astellas Pharma US. It provides a new tac…
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Effects of Donor and Recipient Genetic Expression on Heart, Lung, Liver, or Kidney Transplant Survival
This completed clinical trial from NIAID examined how donor and recipient genetic expression influences survival after heart, lung, liver, a…
-
CLINICAL_TRIALS trial_result · 2013-05-31Clinical Trial Update: Human Mesenchymal Stem Cells Induce Liver Transplant Tolerance [Phase 1]
Phase 1 clinical trial investigating whether human mesenchymal stem cells can induce tolerance in liver transplant recipients.
-
CLINICAL_TRIALS trial_result · 2013-05-20Clinical Trial Update: Efficacy and Safety of Concentration-controlled Everolimus to Eliminate or to Reduce Tacrolimus Compared to Tacrolimus in de Novo Liver Transplant Recipients [Phase 3]
A Phase 3 trial evaluating concentration-controlled everolimus to eliminate or reduce tacrolimus compared with tacrolimus alone in de novo l…
-
CLINICAL_TRIALS trial_result · 2013-04-16Clinical Trial Update: Effect of Rapid Transfusion With Fluid Management System 2000® (FMS) [NA]
A completed clinical trial evaluating rapid transfusion with the Fluid Management System 2000 (FMS) in liver transplantation.
-
CLINICAL_TRIALS trial_result · 2013-04-11Clinical Trial Update: Comparing Efficacy and Safety of Tacrolimus With Steroids or Monoclonal Anti-IL2R Antibody in Hepatitis C Virus (HCV) Positive Liver Transplant Patients [Phase 2]
Phase 2 trial evaluating tacrolimus-based immunosuppression with steroids versus a monoclonal anti-IL2R antibody in hepatitis C–positive liv…